Each article is made available under the terms of the . ​All of our articles are available to download individually in PDF format.


β-Thalassaemias: Highlights from the European Hematology Association Scientific Working Group (EHA-SWG) Scientific Meeting on Anaemias: Diagnosis and Treatment in the Omics Era

β-Thalassaemias: Highlights from the European Hematology Association Scientific Working Group (EHA-SWG) Scientific Meeting on Anaemias: Diagnosis and Treatment in the Omics Era

September 22, 2017 at 8:30 AM 0 comments

This article comprises a summary of scientific sessions on β-thalassaemia that took place on 2nd–4th February 2017, as part of the European Hematology Association Scientific Working Group meeting: Anaemias: Diagnosis and Treatment in the Omics Era, in Barcelona, Spain Chairpersons and speakers: Clara Camaschella,1,2 Ali T. Taher,3 Maria-Domenica Cappellini4,5 1. Division of Genetics andRead More

How I Manage Myelofibrosis

How I Manage Myelofibrosis

August 31, 2017 at 8:29 AM 0 comments

*Anca Lupu President of the Romanian Society of Hematology; Vice President of the Romanian Society Haemostasis and Thrombosis; Head of Hematology Department, Colțea Clinical Hospital; Professor of Hematology, University of Medicine and Pharmacy ‘Carol Davila’, Bucharest, Romania *Correspondence to cercetarecoltea@yahoo.com Disclosure: The author has declared no conflicts of interest. Received:Read More

How I Diagnose Hypereosinophilic Syndromes

How I Diagnose Hypereosinophilic Syndromes

August 31, 2017 at 8:28 AM 0 comments

*Simon Kavanagh, Jeffrey H. Lipton Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada *Correspondence to simon.kavanagh@uhn.ca Disclosure: The authors have declared no conflicts of interest. Received: 21.02.17 Accepted: 07.08.17 Citation: EMJ. 2017;2[3]:15-20. Abstract Hypereosinophilic syndromes are a group of disorders characterised byRead More

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

Management of Multiply Relapsed Aggressive Non-Hodgkin Lymphoma: New Perspectives

August 31, 2017 at 8:27 AM 0 comments

This symposium took place on 13th June 2017, as a part of the 14th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland Chairpersons: Eric Van Den Neste,1 Ruth Pettengell2 Speakers: Pier Luigi Zinzani,3 Eric van Den Neste,1 Ruth Pettengell,2 Amjad Hayat,4 Kai Hübel5 1. Department of Haematology, Cliniques Universitaires,Read More

Redefining Later-Line Therapy in Metastatic Colorectal Cancer

Redefining Later-Line Therapy in Metastatic Colorectal Cancer

August 31, 2017 at 8:26 AM 0 comments

This symposium took place on 29th June 2017 as part of the 19th World Congress on Gastrointestinal Cancer in Barcelona, Spain Chairpersons: Andres Cervantes,1 Dirk Arnold2 Speakers: Marc Peeters,3 Julien Taieb4 1. CIBERONC. Department of Medical Oncology, Biomedical Research Institute, Incliva, University of Valencia, Valencia, Spain 2. Instituto CUF deRead More

Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

Management of B-Cell Lymphoma: Where Are We Now and Where Are We Going?

August 31, 2017 at 8:25 AM 0 comments

This symposium took place on 15th June 2017, as part of the 14th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland Chairperson: Gilles Salles1 Speakers: Nathan H. Fowler,2 Umberto Vitolo3 1. Haematology Department, Lyon-Sud University Hospital Complex, Pierre-Bénite, France 2. Department of Lymphoma and Myeloma, University of Texas MDRead More

Inherited Bone Failure Syndromes, Focus on the Haematological Manifestations: A Review

Inherited Bone Failure Syndromes, Focus on the Haematological Manifestations: A Review

August 31, 2017 at 8:16 AM 0 comments

Jessica S. Foglesong,1 Sarah A. Bannon,2 *Courtney D. DiNardo3 1. Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 2. Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 3. Department of Leukemia, The University of Texas MDRead More

Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice?

Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice?

August 31, 2017 at 8:15 AM 0 comments

*Serdal Korkmaz Department of Hematology, Kayseri Training and Research Hospital, Kayseri, Turkey *Correspondence to baranserdalkorkmaz@gmail.com Disclosure: The author has declared no conflicts of interest. Received: 17.03.17 Accepted: 21.06.17 Citation: EMJ. 2017;2[3]:113-120. Abstract Chronic neutrophilic leukaemia (CNL), chronic eosinophilic leukaemia-not otherwise specified (CEL-NOS), and myeloproliferative neoplasm (MPN), unclassifiable are rare clonalRead More

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

August 31, 2017 at 8:14 AM 0 comments

*David Pesántez,1 Adela Rodriguez,1 Aina Oliver-Caldés,2 Pablo Mozas,2 Jordi Esteve2-4 1. Medical Oncology Department, Hospital Clínic of Barcelona, Barcelona, Spain 2. Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain 3. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain 4. University of Barcelona, Barcelona, Spain *Correspondence to pesantez@clinic.cat Disclosure:Read More

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

August 8, 2017 at 8:53 AM 0 comments

This satellite symposium took place on 13th June 2017 as a part of the 14th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland Chairperson: Bruce Cheson1 Speakers: Rosmarie Pfau,2 Mathias Rummel,3 Andrew Davies,4 Gilles Salles5 1. Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington DC, USA 2. Board Member ofRead More